Financial Consulate Lifted By $1.35 Million Its Modine Mfg Co (MOD) Stake; Zynerba Pharmaceuticals (ZYNE) Shorts Decreased By 3.85%

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) had a decrease of 3.85% in short interest. ZYNE’s SI was 2.45M shares in February as released by FINRA. Its down 3.85% from 2.55M shares previously. With 280,500 avg volume, 9 days are for Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)’s short sellers to cover ZYNE’s short positions. The SI to Zynerba Pharmaceuticals Inc’s float is 20.65%. The stock decreased 1.87% or $0.1 during the last trading session, reaching $5.26. About 554,524 shares traded. Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) has declined 60.78% since February 10, 2018 and is downtrending. It has underperformed by 60.78% the SP500. Some Historical ZYNE News: 19/04/2018 – GWPH, ZYNE: Panel votes 13 to 0 that $GWPH’s Epidiolex (cannabidiol) has a favorable risk/benefit profile. – ! $GWPH $ZYNE; 10/04/2018 – ZYNERBA PHARMACEUTICALS INC – EXPECTS TO REPORT TOPLINE RESULTS FROM PHASE 2 BELIEVE 1 CLINICAL TRIAL IN 2019; 26/03/2018 – Zynerba Sees Bets on Its

... read more at: